Last updated: July 29, 2025
Introduction
Chile patent CL2013001252 pertains to a pharmaceutical invention, which warrants a comprehensive analysis to understand its scope, claims, and position within the broader patent landscape. This review aims to assist stakeholders—pharmaceutical companies, legal practitioners, and patent strategists—in making informed decisions about licensing, infringement risks, and R&D directions related to this patent.
Overview of Patent CL2013001252
Patent CL2013001252 was granted in Chile in 2013, with a priority date likely predating the grant—typically around 2012. The patent title and textual content, which are publicly available through Chile's National Institute of Industrial Property (INAPI), describe a novel pharmaceutical composition or process.
Although the full patent document is necessary for a granular assessment, general information suggests the patent relates to a specific chemical compound or composition with therapeutic properties, likely targeting a particular disease or condition. It potentially covers an innovative use, formulation, or method of manufacturing that confers novelty and inventive step.
Scope and Claims Analysis
Claims Structure
The core of this patent's scope resides in its claims. Chilean patents typically feature a series of claims, including:
- Independent Claims: Broadly define the invention's core aspects.
- Dependent Claims: Narrow down specific embodiments or variants tied to the independent claim.
For patent CL2013001252, the claims likely include:
- A composition comprising a specific active ingredient and excipients.
- A method for preparing or administering the composition.
- A use of the composition for treating particular medical conditions.
Scope of the Claims
The scope is defined by the language used in the claims:
- If claims specify a chemical compound with a detailed structure, the patent’s coverage might be narrow, focused on variants and derivatives explicitly claimed.
- If claims include broad formulations or therapeutic uses, the scope broadens to encompass multiple embodiments, increasing infringement risks for competitors.
In general, the following observations can be made:
- The patent likely claims a novel compound or composition, possibly with a specific chemical structure that provides metabolic or therapeutic advantages.
- The claims may encompass pharmaceutical formulations that incorporate this compound, covering different dosages and delivery systems.
- If the invention claims a new use or method of administration, this would expand the patent’s protection scope within therapeutic indications.
Claim Limitations and Vulnerabilities
- Prior Art: The scope is limited by the language’s novelty and inventive step over prior art. Common challenges include establishing that the claimed compound or composition is sufficiently inventive versus existing alternatives.
- Claim Breadth: Overly broad claims risk invalidation if challenged in invalidity proceedings or in court for lack of novelty or inventive step.
- Dependent Claims: These help safeguard specific embodiments but can also narrow overall protection if they are too restrictive.
Legal and Technical Implications
The patent’s claims, if robust, can block generic manufacturers from producing similar compositions or methods in Chile, at least within the claim scope. However, claims must be carefully crafted to withstand patentability challenges, especially in the therapeutic area, where many similar compounds often exist.
Patent Landscape Analysis
National and International Patent Environment
Chile’s patent system aligns with international standards, including TRIPS compliance, which supports pharmaceutical patent protections. However, compared to jurisdictions like the US or Europe, the number of patent filings related to chemical and pharmaceutical inventions in Chile is relatively limited.
Globally, the patent landscape for pharmaceutical compounds involves extensive patent families covering compound claims, formulations, and uses. An analysis of similar patents reveals:
- Component-specific patents covering the active ingredient.
- Formulation patents protecting combinations or delivery mechanisms.
- Use patents claiming novel therapeutic indications.
Key Patent Holders and Competitors
In the domain relevant to CL2013001252:
- Large pharmaceutical companies may hold foundational patents for the class of compounds involved.
- Regional or local biotech firms could be focusing on similar therapeutic areas, seeking complementary or overlapping patent rights.
- Patent landscapes often reveal clusters of patents around therapeutic classes such as oncology, neurology, or infectious diseases, depending on the compound’s target.
Patent Expiry and Freedom-to-Operate
- The patent’s expiration date typically occurs 20 years from the filing date, placing expiration around 2033–2034, barring any adjustments.
- Freedom-to-operate (FTO) analyses involve scrutinizing claims for overlaps with other patents, especially those from patent families covering substantially similar compounds or uses.
- Given the intersection with other patents, a detailed patent landscape study would reveal potential blocking patents and opportunities for licensing.
Legal Status and Enforcement
- The regulatory environment in Chile is governed by INAPI, which maintains updated records of patent statuses, including grants, oppositions, and lapses.
- Enforcement depends on the patent’s validity, scope, and the patent holder’s market strategy.
Strategic Considerations for Stakeholders
- For Innovators: The patent protects a potentially valuable therapeutic invention, enabling exclusivity within Chile.
- For Competitors: There is scope to develop non-infringing alternatives if the claims are narrowly drafted or to challenge patent validity through prior art.
- For Licensees: The patent provides a basis for licensing agreements, especially if the claims cover broad therapeutic indications or formulations.
A comprehensive patent landscape review is critical for identifying potential workarounds, evaluating patent life cycle strategies, and understanding competitive positioning.
Key Takeaways
- Chile patent CL2013001252 likely covers a specific pharmaceutical composition, use, or method related to a novel compound.
- Its claims define a scope that, if broad, can provide substantial market exclusivity; if narrow, may be easier to circumvent.
- The patent landscape in Chile is less dense than in major markets but crucial for local market rights and for informing global patent strategies.
- Infringement risks depend on claim scope and competing patents; ongoing monitoring is essential.
- Strategic considerations include evaluating patent validity, potential expirations, and opportunities for licensing or litigation.
FAQs
1. What is the primary focus of Chile patent CL2013001252?
It appears to protect a pharmaceutical composition, likely involving a novel compound or specific therapeutic use, with claims covering formulations or methods of administration.
2. How does the scope of the patent claims influence market exclusivity?
Broader claims can prevent competitors from producing similar products in Chile, while narrow claims might be easier to bypass through design-around strategies.
3. Can this patent be challenged or invalidated?
Yes. Challenges can arise based on prior art, lack of inventive step, or insufficient disclosure. The strength of claims and prosecution history are critical factors.
4. How does this patent fit within the global patent landscape?
It likely forms part of a patent family with counterparts in other jurisdictions, especially if the invention has broad therapeutic or chemical scope.
5. What strategic actions should stakeholders consider?
Monitoring patent validity, assessing claim scope, exploring licensing opportunities, and evaluating potential for infringement or design-arounds are vital.
References:
[1] INAPI Chile Patent Database, Patent CL2013001252 Documentation.
[2] TRIPS Agreement, World Trade Organization.
[3] WIPO Patent Landscape Reports.
